Milly E. de Jonge
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Pathology and Forensic Medicine top 10%
- Chemotherapy-induced organ toxicity mitigation
Papers in
-
- Chemotherapy-induced organ toxicity mitigation 12
- Oncology 9
- Cancer Treatment and Pharmacology 7
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- Jos H. Beijnen (16 shared papers)Alwin D. R. Huitema (15 shared papers)Sjoerd Rodenhuis (14 shared papers)Jan H.M. Schellens (4 shared papers)Hilde Rosing (2 shared papers)M. Holtkamp (1 shared paper)Corine Ekhart (1 shared paper)Ron A. A. Mathôt (2 shared papers)
- Journals
- Clinical Cancer Research (3 papers)Therapeutic Drug Monitoring (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Clinical Pharmacokinetics (2 papers)British Journal of Cancer (1 paper)
- Partner nations
- Netherlands
In The Last Decade
Milly E. de Jonge
17 papers receiving 844 citations
Peers
Comparison fields: 5 of 111
- Pharmacology 150
- Pathology and Forensic Medicine 211
- Hematology 128
- Oncology 282
- Occupational Therapy 38
Countries citing papers authored by Milly E. de Jonge
This map shows the geographic impact of Milly E. de Jonge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milly E. de Jonge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milly E. de Jonge more than expected).
Fields of papers citing papers by Milly E. de Jonge
This network shows the impact of papers produced by Milly E. de Jonge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milly E. de Jonge. The network helps show where Milly E. de Jonge may publish in the future.
Co-authors
The 17 scholars most cited alongside Milly E. de Jonge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 333 | |
| 2 | 2005 | 88 | |
| 3 | 2005 | 62 | |
| 4 | 2006 | 55 | |
| 5 | 2005 | 52 | |
| 6 | 2004 | 44 | |
| 7 | 2004 | 44 | |
| 8 | 2006 | 41 | |
| 9 | 2005 | 27 | |
| 10 | 2004 | 23 | |
| 11 | 2005 | 22 | |
| 12 | 2005 | 21 | |
| 13 | 2005 | 19 | |
| 14 | 2005 | 15 | |
| 15 | 2005 | 11 | |
| 16 | 2003 | 6 | |
| 17 | 2005 | 4 |
About Milly E. de Jonge
Milly E. de Jonge is a scholar working on Pathology and Forensic Medicine, Oncology, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Molecular Biology, having authored 17 papers that have together received 867 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (12 papers), Cancer Treatment and Pharmacology (7 papers), Acute Lymphoblastic Leukemia research (7 papers), Pharmacological Effects and Toxicity Studies (3 papers), Cancer therapeutics and mechanisms (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Childhood Cancer Survivors' Quality of Life (2 papers) and Chemical Reactions and Isotopes (1 paper). The work is most often cited by research in Pharmacology (150 citations), Pathology and Forensic Medicine (211 citations), Hematology (128 citations), Oncology (282 citations) and Occupational Therapy (38 citations). Milly E. de Jonge has collaborated with scholars based in Netherlands. Frequent co-authors include Jos H. Beijnen, Alwin D. R. Huitema, Sjoerd Rodenhuis, Jan H.M. Schellens, Hilde Rosing, M. Holtkamp, Corine Ekhart, Ron A. A. Mathôt, M. J. X. Hillebrand and Nico van Zandwijk. Their work appears in journals such as Clinical Cancer Research, Therapeutic Drug Monitoring, Cancer Chemotherapy and Pharmacology, Clinical Pharmacokinetics and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.